CSIMarket
 

Fibrocell Science, Inc.  (FCSC)
Other Ticker:  
 

Fibrocell Science,'s Working Capital Per Sales

FCSC's Working Capital and Revenue growth



FCSC Working Capital Per Revenue (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Working Capital Change 2.85 % 28.57 % -16.29 % -8.27 % 67.57 %
Y / Y Revenue Change 1071.26 % 8904.96 % - - -
Working Capital Per Revenue 0.55 0.57 6.09 6.69 49.53
Total Ranking # 2961 # 1590 # 2562 # 2952 # 0
Seq. Working Capital Change -15.51 % 96.3 % -26.8 % -15.29 % 5.62 %
Seq. Revenue Change -95.32 % 39521.82 % -96.69 % 1810.34 % -64.05 %





Comment on FCSC's Working Capital Per Revenue in the third quarter 2019
Fibrocell Science,'s Working Capital Per Revenue in the Q3 2019 sequentially fell to 0.55 a new company low.

Within Healthcare sector 94 other companies have achieved lower Working Capital Per Revenue during the Q3 2019. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2019, compared to previous quarter from 1590 to 2961.
Working Capital Per Revenue Ranking
Within: No.
Industry # 36
Sector # 95
S&P 500 # 2961


Working Capital Per Revenue Statistics
High Average Low
298.38
93.58
0.55
(Sep 30 2014)   (Sep 30 2019)



Financial Statements
Fibrocell Science,'s Working Capital $ 15 Millions Visit FCSC's Balance sheet
Fibrocell Science,'s Revenues $ 1 Millions Visit FCSC's Income Statement
Where are FCSC's Sales coming from? Visit FCSC's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2019, within Healthcare Sector Working Capital Per Revenue
Neuronetics inc   1.50 
Biocept Inc   1.49 
Navidea Biopharmaceuticals Inc   1.44 
Durect Corp  1.43 
Enzon Pharmaceuticals inc   1.42 
Arcturus Therapeutics Holdings Inc   1.40 
Exact Sciences Corporation  1.40 
Invitae Corporation  1.40 
Tandem Diabetes Care Inc   1.38 
Athenex Inc   1.36 
Acorda Therapeutics Inc   1.34 
Pfenex Inc   1.32 
Chemocentryx Inc.  1.29 
Halozyme Therapeutics Inc   1.28 
Biolife Solutions Inc   1.28 
Protalix Biotherapeutics inc   1.28 
Seres Therapeutics Inc   1.27 
Htg Molecular Diagnostics Inc  1.26 
Axogen inc   1.26 
Rigel Pharmaceuticals Inc  1.25 
Cyclo Therapeutics Inc   1.25 
Ptc Therapeutics inc   1.24 
Veracyte inc   1.24 
Nuwellis Inc   1.24 
Iradimed Corporation  1.23 
Lannett Company Inc  1.20 
Prophase Labs Inc   1.20 
Orasure Technologies Inc  1.20 
Adaptive Biotechnologies Corporation  1.17 
Titan Pharmaceuticals Inc   1.16 
Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com